Skip to content

Clinical trials

Completed Coronary Artery Disease trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Status: Completed Country / region: Hong Kong Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20121
20141
20172
20183
20192
20201
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong4
Abbott Medical Devices3
AstraZeneca2
Biotronik AG1
CSL Behring1
Chinese University of Hong Kong1
Medtronic Vascular1
Prof. Stephen Lee1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease14
Hemorrhagic Stroke3
Ischemic Stroke3
Acute Coronary Syndrome2
Anemia2
Atherosclerosis2
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Heart Failure2
Hematologic Diseases2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.